Patoloxía Molecular das Doenzas Raras
PatMol-DR
![Foto de Patoloxía Molecular das Doenzas Raras](/img/grupo.png)
![Foto de Hannover Medical School](/img/noimage_org.png)
Hannover Medical School
Hanóver, AlemaniaPublicacións en colaboración con investigadores/as de Hannover Medical School (2)
2023
-
Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension
European Journal of Heart Failure, Vol. 25, Núm. 7, pp. 936-955
2009
-
Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial
The Lancet, Vol. 374, Núm. 9704, pp. 1840-1848